Submitted by Anonymous (not verified) on 5 May 2026 - 14:52
Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 30/03/2023, Revision: 13, Status: Authorised
Source: